| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1467.86 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1425.47 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1459.51 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 1256.13 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 1452.18 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 1599.87 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1428.03 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1253.23 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1415.49 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1342.8 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1450.83 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1477.84 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1220.16 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1338.88 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1483.48 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1239.18 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1427.17 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1271.78 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1710.71 | 97 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1548.75 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1438.44 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1454.75 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1448.84 | 97 |